# Simplified Asthma Inhalers This Once-a-Day Inhaler Provides 24-Hour Relief By Vasiliki Marapas | Published 2015-01-23 | Lifestyle Source: Trend Hunter, https://www.trendhunter.com/trends/once-a-day-inhaler References: [dailymail](http://www.dailymail.co.uk/health/article-2535605/New-day-inhaler-ease-suffering-asthma-patients-approved-use-Britain.html) A new once-a-day inhaler by the name of Relvar Ellipta will be available for asthma sufferers in Britain. The inhaler combines a daily dose of steroid, which is used to reduce inflammation in the airways, with a new type of long-lasting beta2 agonist, which focuses on dilation. The product speaks to a need for simplicity, as studies show that many asthma patients find it difficult to manage two separate inhalers. The long-lasting drug will provide relief throughout the entire day, although some users may have to carry a blue inhaler for "immediate relief." The drug is not limited to those with asthma however; it can also be used to combat a long list of respiratory illnesses, such as COPD. ## Trend Insights (Trend Hunter) - Score: 2.0/10 - Popularity: 24% | Activity: 27% | Freshness: 8% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America, Europe, Asia ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Lifestyle](https://www.trendhunter.com/lifestyle) > [Health](https://www.trendhunter.com/health) ## Key Themes ### Key Themes Behind This Trend - **Simplified Asthma Treatment:** The development of a once-a-day inhaler for asthma sufferers addresses the need for simpler treatment options. - **Combination Inhalers:** The combination of a steroid and a long-lasting beta2 agonist in a single inhaler offers convenience and better management of respiratory illnesses. - **Expanded Applications for Inhalers:** The use of the new inhaler beyond asthma treatment opens up opportunities for treating various respiratory illnesses such as COPD. ### Where This Applies - **Pharmaceuticals:** The development and manufacturing of simplified inhalers provide opportunities for pharmaceutical companies to enhance asthma and respiratory illness treatments. - **Healthcare:** The introduction of once-a-day inhalers in healthcare facilitates improved management of asthma and respiratory conditions, potentially leading to better patient outcomes. - **Medical Devices:** The innovation in inhaler technology creates disruptive opportunities for medical device companies to create more efficient and user-friendly respiratory treatment devices. ## Related on Trend Hunter - [Digitized Medication Inhalers](https://www.trendhunter.com/trends/mae-inhaler.md) - [Respiratory Health Formulas](https://www.trendhunter.com/trends/life-extension.md) - [Asthma Support Platforms](https://www.trendhunter.com/trends/asthma-friend.md) - [Wearable Allergy-Alleviating Purifiers](https://www.trendhunter.com/trends/respiray-wear-a.md) - [Life-Saving Nasal Sprays](https://www.trendhunter.com/trends/neffy.md) - [Lung Health Wearables](https://www.trendhunter.com/trends/respira.md) - [Respiratory System Cleansing Devices](https://www.trendhunter.com/trends/salt-air-therapy.md) - [Updated Respiratory Training Systems](https://www.trendhunter.com/trends/respiratory-training-system.md) - [Steroid-Free Antihistamine Nasal Sprays](https://www.trendhunter.com/trends/astepro.md)